Mölnlycke produces healthcare products such as bandages and disposable products for use in operations. The company is being sold for €2.85 billion, nearly 26 billion kronor. The seller is venture capital company Apax Partners.
Gothenburg-based Mölnlycke had a turnover of €760 million (6.9 billion kronor) last year, and had an operating profit before write-downs of around €230 million (2.1 billion kronor).
The deal will mainly be financed through external loans. Mölnlycke will be owned by a holding company in which Investor and Morgan Stanley own equal shares.
Mölnlycke’s management team will be minority shareholders of the company.